Floatz logo

18 assets in Diffuse Large B-Cell Lymphoma Activated B-Cell Type

Therapeutic assets addressing Diffuse Large B-Cell Lymphoma Activated B-Cell Type, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cyclophosphamide
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)P3BB (67)
Rituximab
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
Mayo ClinicP2/3BB (66)
Adriamycin
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)P2/3BB (64)
Prednisone
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)P2/3BB (64)
Vincristine Sulfate
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)P2/3BB (64)
Camustine
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)P3B (60)
Cytarabine
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)P3B (60)
Etoposide
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)P3B (60)
Ibrutinib
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)P3B (60)
Melphalan
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)P3B (60)
Azacitidine
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)P2/3B (57)
Recombinant Human Hyaluronidase
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)P2/3B (57)
Golcadomide
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
Mayo ClinicP2CCC (53)
Nivolumab
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)P2CCC (53)
Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)P2CC (44)
Tegavivint
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
Lapo AlinariP1CC (43)
Apamistamab
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
Memorial Sloan Kettering Cancer CenterEarly P1C (39)
xl114
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
ExelixisP1NR ()